Marimed (MRMD) Non-Current Assets (2013 - 2026)
Marimed (MRMD) posted quarterly Non-Current Assets of $140.4 million for Q1 2026, down 6.4% year-over-year from $150.0 million in Q1 2025, and down 2.01% quarter-over-quarter from $143.3 million in Q4 2025.
Marimed (MRMD) Non-Current Assets (2013 - 2026) Analysis & Trends
Marimed (MRMD) has reported Non-Current Assets for 14 consecutive years, with $140.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 6.4% year-over-year to $140.4 million; the TTM figure through Mar 2026 stood at $370.8 million (down 39.7% YoY), while the FY2025 annual figure was $143.3 million, down 6.65% from the prior year.
- Non-Current Assets declined to $140.4 million in Q1 2026 per MRMD's latest filing, from $143.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $156.0 million in Q3 2024 and bottomed at -$60.1 million in Q3 2025.
- Historically, Non-Current Assets has averaged $121.8 million across 5 years, with a median of $140.4 million in 2026.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 62.13% — and 2025, when it slumped 138.52%.
- Marimed's Non-Current Assets stood at $108.1 million in 2022, then soared by 33.9% to $144.7 million in 2023, then gained by 6.07% to $153.5 million in 2024, then slipped by 6.65% to $143.3 million in 2025, then retreated by 2.01% to $140.4 million in 2026.
- Business Quant data shows MRMD's Non-Current Assets at $140.4 million in Q1 2026, $143.3 million in Q4 2025, and -$60.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | 138.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 138.80 Mn |
| Mar 31, 2026 | 140.40 Mn |
| Dec 31, 2025 | 143.28 Mn |
| Sep 30, 2025 | -60.09 Mn |
| Jun 30, 2025 | 147.24 Mn |
| Mar 31, 2025 | 150.00 Mn |
| Dec 31, 2024 | 153.48 Mn |
| Sep 30, 2024 | 156.00 Mn |
| Jun 30, 2024 | 155.48 Mn |
| Mar 31, 2024 | 146.44 Mn |
| Dec 31, 2023 | 144.69 Mn |
| Sep 30, 2023 | 140.03 Mn |
| Jun 30, 2023 | 131.45 Mn |
| Mar 31, 2023 | 125.02 Mn |
| Dec 31, 2022 | 108.06 Mn |
| Sep 30, 2022 | 103.82 Mn |
| Jun 30, 2022 | 102.33 Mn |
| Mar 31, 2022 | 82.67 Mn |
| Dec 31, 2021 | 78.59 Mn |
| Sep 30, 2021 | 68.45 Mn |